Cannabis 3.0: The Dawn of Cannabis as a True Consumer Packaged Good
Thursday, April 08, 2021
|
Thursday, April 08, 2021
1:00 PM - 1:45 PM
N/A
Thursday, April 08, 2021
Cannabis 3.0: The Dawn of Cannabis as a True Consumer Packaged Good
The Cannabis Industry in Canada and around the world is evolving. Whether a fully recreational market like Canada, a CBD unrestricted market like the USA, or a growing medical market in the EU that’s in its infancy, Cannabis as a category over the mid-to-long term is set for exponential growth.
Get ready to transform your view of Cannabis, in fact, get ready for Cannabis to be transformed. The Valens Company believes that Cannabis as an adult recreational product or strictly a medical product is changing as we speak, and Cannabis 3.0 will bring with it new consumer habits, new uses and new daily rituals.
Backed by scientific data, consumer focused insights, and an array of Cannabinoid applications, get ready for the Dawn of Cannabis as a True CPG product.
Using consumer insights, category examples and an exploration of consumer needs, at the end of this session you will:
- Have a greater understanding of the Cannabis category, its growth and evolution
- Learn how cannabinoids can go from a traditional view of recreational or medical products, to consumer packaged goods that are a part of consumers' daily rituals
Registration Fees
Price Description | Amount |
---|---|
Webinar Registration | $0.00 |
Golf Registration Fees
Speakers
Jeff Fallows President, The Valens Company Jeff Fallows is an accomplished finance professional with
over 20 years of experience working on a wide range of financial transactions
in the cannabis, consumer products and industrial products industries including
mergers and acquisitions, initial public offerings, private placements, and
strategic reviews both domestically and internationally. He spent the last 10
years working with a number of cannabis companies to raise capital and has
advised on some of the largest transactions in the sector. Prior to joining The
Valens Company, Jeff was a Managing Director at AltaCorp Capital Inc. where he
was the Head of Life Sciences and Diversified Industries investment banking
teams. Jeff focuses on executing on domestic and international growth opportunities,
capital markets strategy and assisting with the overall corporate strategy of
the Company.
|